4.6 Article

Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Variant TREM2 Signaling in Alzheimer's Disease

Edward O. Olufunmilayo et al.

Summary: Alzheimer's disease is the most common form of dementia, with individuals in low- and middle-income countries being the most affected. Variants of the TREM2 receptor have been found to increase the risk of Alzheimer's disease. However, the specific signaling processes triggered by these receptor variants are not well understood.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Article Neurosciences

Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells

Christophe Boudesco et al.

Summary: The receptor Triggering Receptor Expressed on Myeloid cells 2 (TREM2) can be activated by antibodies targeting the stalk region, and negatively charged molecules like phosphatidylserine can act as endogenous ligands. Optimized liposomes can selectively stimulate TREM2 and have stability and activity.
Article Multidisciplinary Sciences

Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease

Daniel C. Ellwanger et al.

Summary: TREM2 plays a critical role in microglia activation trajectories, with ligand engagement being essential for certain activation pathways. Activation trajectories induced by stimuli are more prominent in female mice than male mice. Injection of hT2AB can replenish depleted microglial pools lacking certain activation trajectories.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Neurosciences

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

Seung-Hye Lee et al.

Summary: Loss-of-function TREM2 mutations increase Alzheimer's disease risk. TREM2 deletion has protective functions in beta-amyloid and tau pathologies; in the presence of beta-amyloid pathology, Trem2 deletion exacerbates tau accumulation and spreading, promoting neurodegeneration. TREM2 may slow AD progression and reduce tau-driven neurodegeneration by limiting beta-amyloid's facilitation of pathogenic tau spreading.

NEURON (2021)

Article Cell Biology

AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation

Faten A. Sayed et al.

Summary: The R47H variant of TREM2 increases risk for late-onset Alzheimer's disease and induces inflammatory signatures and hyperactivation of AKT in microglial subpopulations. In a tauopathy mouse model, R47H exacerbates spatial memory deficits and transcriptomic changes in microglia, which can be reversed by AKT inhibition. Identifying disease-enhancing mechanisms of the R47H mutation, the study supports AKT signaling inhibitors as a potential strategy to treat AD.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Neurosciences

Role of TREM2 in Alzheimer's Disease: A Long Road Ahead

Bhargavi Kulkarni et al.

Summary: The role and variants of TREM2 play an important role in the progression of AD, with studies showing its relationship with neuroinflammation, β-amyloid burden, and tau pathology. The potential of soluble TREM2 as an effective biomarker and neuroprotection in AD is discussed, with a focus on developing therapeutic agents targeting TREM2.

MOLECULAR NEUROBIOLOGY (2021)

Article Multidisciplinary Sciences

Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice

Kathleen M. Schoch et al.

Summary: The study found that transient reduction of Trem2 messenger RNA levels in APP/PS1 mice significantly reduced plaque deposition and attenuated microglial association around plaques. The results suggest that Trem2 reduction may activate microglia and aid in plaque removal.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Microglial? signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome

Katharina Cosker et al.

Summary: The study revealed that microglia carrying the TREM2 R47H variant have impaired response to cell damage signals, potentially contributing to the progression of late onset Alzheimer's disease.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation

Anna Vilalta et al.

Summary: Wild-type TREM2 protects against amyloid aggregation and neurotoxicity by releasing sTREM2, while the R47H variant promotes Aβ aggregation and neurotoxicity.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll-like Receptor 4

David Hans Allendorf et al.

JOURNAL OF NEUROCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia

Nicole Scott-Hewitt et al.

EMBO JOURNAL (2020)

Review Biochemistry & Molecular Biology

The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway

Aleksandra Deczkowska et al.

Article Neurosciences

Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice

Wenhui Qu et al.

JOURNAL OF NEUROSCIENCE (2020)

Article Neurosciences

TREM2 triggers microglial density and age-related neuronal loss

Bettina Linnartz-Gerlach et al.

Review Oncology

Cystatin F as a regulator of immune cell cytotoxicity

Janko Kos et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)

Article Biochemistry & Molecular Biology

Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2

Athena Sudom et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Neurosciences

The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease

Paul J. Cheng-Hathaway et al.

MOLECULAR NEURODEGENERATION (2018)

Article Immunology

Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau

Silvia S. Kang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Neurosciences

Microglial signatures and their role in health and disease

Oleg Butovsky et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Review Neurosciences

New insights into the role of TREM2 in Alzheimer's disease

Maud Gratuze et al.

MOLECULAR NEURODEGENERATION (2018)

Article Multidisciplinary Sciences

TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy

Cheryl E. G. Leyns et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

RIPK1 mediates a disease-associated microglial response in Alzheimer's disease

Dimitry Ofengeim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Geriatrics & Gerontology

Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

Matthias Brendel et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Article Biochemistry & Molecular Biology

A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease

Hadas Keren-Shaul et al.

Article Biochemistry & Molecular Biology

TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model

Yaming Wang et al.

Article Multidisciplinary Sciences

Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

Carlo Condello et al.

NATURE COMMUNICATIONS (2015)

Article Geriatrics & Gerontology

Frontobasal gray matter loss is associated with the TREM2 p.R47H variant

Elkin O. Luis et al.

NEUROBIOLOGY OF AGING (2014)

Article Medicine, General & Internal

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

Thorlakur Jonsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

TREM2 Variants in Alzheimer's Disease

Rita Guerreiro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Biochemistry & Molecular Biology

Neuronal Death Induced by Nanomolar Amyloid β Is Mediated by Primary Phagocytosis of Neurons by Microglia

Urte Neniskyte et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemical Research Methods

A rapid Percoll gradient procedure for preparation of synaptosomes

Peter R. Dunkley et al.

NATURE PROTOCOLS (2008)

Article Immunology

Pattern recognition by TREM-2: Binding of anionic ligands

MR Daws et al.

JOURNAL OF IMMUNOLOGY (2003)